SCHEMBL9684974

SCHEMBL9684974

CN(CCCCCCCN=C=O)C(=O)OCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.46
MAOB P27338 1/20 0.46
KEAP1 Q14145 2/20 0.44
NFE2L2 Q16236 2/20 0.44
CCR6 P51684 1/20 0.43
PAX8 Q06710 1/20 0.43
ALDH1A1 P00352 3/20 0.41
BCHE P06276 1/20 0.41
ACHE P22303 1/20 0.41
F13A1 P00488 1/20 0.41
TGM2 P21980 1/20 0.41
TGM1 P22735 1/20 0.41
ABCB1 P08183 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
CHRNB2 P17787 1/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
CHRNA4 P43681 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9685806 1.00 MAOA (0.46) MAOAMAOBKEAP1NFE2L2CCR6
SCHEMBL9684838 0.84 CCR6 (0.52) MAOAMAOBKEAP1NFE2L2CCR6
SCHEMBL990966 0.84 ALDH1A1 (0.43) MAOBALDH1A1MAPT
SCHEMBL3170360 0.81 CCR6 (0.52) CCR6PAX8ALDH1A1BCHEACHE
SCHEMBL8424282 0.81 CCR6 (0.52) CCR6PAX8ALDH1A1BCHEACHE
SCHEMBL392019 0.80 HTT (0.50) CCR6PAX8ALDH1A1BCHEACHE
SCHEMBL28002371 0.80 HTT (0.50) CCR6PAX8ALDH1A1BCHEACHE
SCHEMBL30805121 0.80 CCR6 (0.48) CCR6PAX8ALDH1A1BCHEACHE
SCHEMBL27267384 0.80 CCR6 (0.48) CCR6PAX8ALDH1A1BCHEACHE
SCHEMBL19346032 0.80 CCR6 (0.53) CCR6PAX8ALDH1A1BCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0513703-A2 Carbamate esters of eseroline having anticholinesterase activity, a process for their preparation and relative pharmaceutical compositions containing them as the active principle MAGIS FARMACEUTICI S.p.A. (IT) 1992-11-19 EP disclosed